Evidence map›Paper›PMID 27920091›Full record

ArticleDiabetes2017

Interferon-γ Limits Diabetogenic CD8

John P Driver, Jeremy J Racine, Cheng Ye, Deanna J Lamont, Brittney N Newby, Caroline M Leeth, Harold D Chapman, Todd M Brusko, Yi-Guang Chen, Clayton E Mathews and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Type 1 diabetesNPJ autoimmunity · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. IFN-γ, should not be ignored in SLE.Frontiers in immunology · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

John P DriverDepartment of Animal Sciences, University of Florida, Gainesville, FL jdriver@ufl.edu dave.serreze@jax.org.
Jeremy J RacineThe Jackson Laboratory, Bar Harbor, ME.
Cheng YeDepartment of Animal Sciences, University of Florida, Gainesville, FL.
Deanna J LamontThe Jackson Laboratory, Bar Harbor, ME.
Brittney N NewbyDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL.
Caroline M LeethThe Jackson Laboratory, Bar Harbor, ME.
Harold D ChapmanThe Jackson Laboratory, Bar Harbor, ME.
Todd M BruskoDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL.
Yi-Guang ChenDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
Clayton E MathewsDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL.
David V SerrezeThe Jackson Laboratory, Bar Harbor, ME jdriver@ufl.edu dave.serreze@jax.org.
Jackson Laboratory · USUniversity of Florida · USMedical College of Wisconsin · US

Funding

Project 3P01AI042288 · NIAID · UNIVERSITY OF FLORIDA · PI Todd Michael Brusko · 1997 to 2026
$32.9M
Diabetogenic Role of MHC Class I Alleles in NOD MiceR01DK046266 · NIDDK · JACKSON LABORATORY · PI SERREZE, DAVID V · 2000 to 2018
$7.2M
B-lymphocyte Targeting Therapies for Autoimmune DiabetesR01DK095735 · NIDDK · JACKSON LABORATORY · PI SERREZE, DAVID V · 2013 to 2025
$6.2M
Genetic Regulation of Human Beta Cell DestructionUC4DK104194 · NIDDK · UNIVERSITY OF FLORIDA · PI MATHEWS, CLAYTON E · 2014 to 2014
$3.1M
mt-Nd2 and Resistance to Autoimmune DiabetesR01DK074656 · NIDDK · UNIVERSITY OF FLORIDA · PI MATHEWS, CLAYTON E · 2006 to 2015
$2.8M
Type 1 IFN in Type 1 Diabetes: Influencing Beta-Cell and CD8+ T cell interactionsF30DK105788 · NIDDK · UNIVERSITY OF FLORIDA · PI NEWBY, BRITTNEY N · 2015 to 2018
$148k
mt-Nd2 and resistance to autoimmune diabetesR56DK074656 · NIDDK · UNIVERSITY OF FLORIDA · PI MATHEWS, CLAYTON E · 2011 to 2011
$107k
DIABETOGENIC ROLE OF H-2G7 CLASS I ALLELES IN NOD MICER29DK046266 · NIDDK · JACKSON LABORATORY · PI SERREZE, DAVID V. · 1993 to 1998
–
NIAID NIH HHS P01 AI042288NIDDK NIH HHS F30 DK105788NIDDK NIH HHS R01 DK046266NIDDK NIH HHS R01 DK074656NIDDK NIH HHS R01 DK095735NIDDK NIH HHS R29 DK046266NIDDK NIH HHS R56 DK074656NIDDK NIH HHS UC4 DK104194
6 · The paper itself

Abstract

Type 1 diabetes development in the NOD mouse model is widely reported to be dependent on high-level production by autoreactive CD4

Indexed as

Adoptive TransferAnimalsCD8-Positive T-LymphocytesCells, CulturedDiabetes Mellitus, Type 1FemaleHumansInterferon-gammaLymphocyte ActivationMiceMice, Inbred NODMice, TransgenicReceptors, Antigen, T-CellReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSpleenInterferon-gammaReceptors, Antigen, T-CellRNA, MessengerStat1 protein, mouseSTAT1 Transcription FactorStat4 protein, mouseSTAT4 Transcription Factor

Identifiers

PMID27920091
PMCPMC5319715
OpenAlexW2560599417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.